Banco de Sabadell’s iShares Biotechnology ETF IBB Stock Holding History

Banco de Sabadell’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-550	Closed	-$81K	–	208
2021 Q1	$81K	Hold	550	–	–	0.01%	265
2020 Q4	$84K	Hold	550	–	–	0.01%	269
2020 Q3	$74K	Buy	+550	New	+$74.6K	0.01%	304
2019 Q3	–	Sell	-550	Closed	-$60K	–	357
2019 Q2	$60K	Buy	+550	New	+$58.5K	0.01%	322
2019 Q1	–	Sell	-550	Closed	-$53K	–	377
2018 Q4	$53K	Buy	+550	New	+$58.4K	0.01%	364

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Banco de Sabadell's IBB Position: Q2 2021 in Review

Banco de Sabadell sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 550 shares — an estimated $81K sold.

Banco de Sabadell first reported a position in IBB in Q4 2018 and held it in 5 quarters. The position peaked at $84K in Q4 2020. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

Banco de Sabadell reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
Banco de Sabadell sold 550 iShares Biotechnology ETF shares in Q2 2021, an estimated $81K.
Banco de Sabadell first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 5 quarters.
Banco de Sabadell's iShares Biotechnology ETF position peaked at $84K in Q4 2020.
863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Banco de Sabadell's 13F filing for Q2 2021, filed 13 Aug 2021.